| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/SJ.ONC.1207560 |
| P8608 | Fatcat ID | release_efely3dv3jcndccevyegp4reru |
| P698 | PubMed publication ID | 15048079 |
| P5875 | ResearchGate publication ID | 8652912 |
| P50 | author | Andreas Widschwendter | Q115512994 |
| Andreas Gschwendtner | Q71921278 | ||
| Elisabeth Müller-Holzner | Q115512993 | ||
| P2093 | author name string | Steven I Reed | |
| Martin Widschwendter | |||
| Charles H Spruck | |||
| Christian Marth | |||
| Hannes M Müller | |||
| Georg Goebel | |||
| Martin Erdel | |||
| Heidi M Fiegl | |||
| Michael M Hubalek | |||
| P2860 | cites work | Cyclin-dependent kinase control of centrosome duplication | Q24673544 |
| Cyclin E and survival in patients with breast cancer | Q27824788 | ||
| Archipelago regulates Cyclin E levels in Drosophila and is mutated in human cancer cell lines | Q28188140 | ||
| Human F-box protein hCdc4 targets cyclin E for proteolysis and is mutated in a breast cancer cell line | Q28188152 | ||
| Distinct roles for cyclins E and A during DNA replication complex assembly and activation | Q28206467 | ||
| Phosphorylation-dependent ubiquitination of cyclin E by the SCFFbw7 ubiquitin ligase | Q28215069 | ||
| DNA copy number losses in human neoplasms | Q33733232 | ||
| Regulation of G(1) cyclin-dependent kinases in the mammalian cell cycle | Q34076834 | ||
| Induction of mammary gland hyperplasia and carcinomas in transgenic mice expressing human cyclin E | Q36564958 | ||
| Malignant transformation by cyclin E and Ha-Ras correlates with lower sensitivity towards induction of cell death but requires functional Myc and CDK4. | Q41076718 | ||
| Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system | Q41483751 | ||
| Deregulated cyclin E induces chromosome instability | Q41692394 | ||
| Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation | Q42809976 | ||
| Fourth updated ESACP consensus report on diagnostic DNA image cytometry. | Q52044386 | ||
| DNA amplifications and aneuploidy, high proliferative activity and impaired cell cycle control characterize breast carcinomas with poor prognosis. | Q54560489 | ||
| P433 | issue | 23 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 4187-4192 | |
| P577 | publication date | 2004-05-01 | |
| P1433 | published in | Oncogene | Q1568657 |
| P1476 | title | Cyclin E dysregulation and chromosomal instability in endometrial cancer | |
| P478 | volume | 23 |
| Q36848850 | A jekyll and hyde role of cyclin E in the genotoxic stress response: switching from cell cycle control to apoptosis regulation |
| Q80608586 | Aberrant expression of cell cycle regulators in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma |
| Q40018751 | Adenovirus E1B55K region is required to enhance cyclin E expression for efficient viral DNA replication. |
| Q90411105 | CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D1- mantle cell lymphoma |
| Q37149363 | CENP-F expression is associated with poor prognosis and chromosomal instability in patients with primary breast cancer |
| Q30480596 | Cyclin E overexpression impairs progression through mitosis by inhibiting APC(Cdh1). |
| Q36186117 | Cyclin-Dependent Kinase Inhibitors as Anticancer Therapeutics |
| Q83919587 | Deregulated cyclin E promotes p53 loss of heterozygosity and tumorigenesis in the mouse mammary gland |
| Q37151091 | Dual CCNE1/PIK3CA targeting is synergistic in CCNE1-amplified/PIK3CA-mutated uterine serous carcinomas in vitro and in vivo |
| Q33564004 | Evidence for a p27 tumor suppressive function independent of its role regulating cell proliferation in the prostate |
| Q44825377 | Expression of cyclin A, cyclin E and p27 in normal, hyperplastic and frankly malignant endometrial samples |
| Q29616127 | FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation |
| Q27852932 | FBXW7 mutations in patients with advanced cancers: clinical and molecular characteristics and outcomes with mTOR inhibitors |
| Q58797685 | FBXW7: a critical tumor suppressor of human cancers |
| Q46661944 | Fbw7 regulates the activity of endoreduplication mediators and the p53 pathway to prevent drug-induced polyploidy. |
| Q24310626 | Fbxw7 regulates lipid metabolism and cell fate decisions in the mouse liver |
| Q49477276 | Fbxw7 regulates renal cell carcinoma migration and invasion via suppression of the epithelial-mesenchymal transition |
| Q40417959 | Infrequent mutations of Archipelago (hAGO, hCDC4, Fbw7) in primary ovarian cancer |
| Q34389043 | MiR-495 regulates proliferation and migration in NSCLC by targeting MTA3. |
| Q37216927 | NFAT1 transcription factor regulates cell cycle progression and cyclin E expression in B lymphocytes |
| Q35006035 | Overexpression of TROP2 predicts poor prognosis of patients with cervical cancer and promotes the proliferation and invasion of cervical cancer cells by regulating ERK signaling pathway |
| Q33892360 | Ras activity regulates cyclin E degradation by the Fbw7 pathway. |
| Q24307181 | The glomuvenous malformation protein Glomulin binds Rbx1 and regulates cullin RING ligase-mediated turnover of Fbw7 |
Search more.